Delayed-maturation theory of obsessive-compulsive disorder

Innovations and Growth Opportunities in Novel Diagnostics, Monitoring Technologies and Advanced Medical Devices 2022 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 30, 2022

The "Innovations and Growth Opportunities in Novel Diagnostics, Monitoring Technologies and Advanced Medical Devices" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Innovations and Growth Opportunities in Novel Diagnostics, Monitoring Technologies and Advanced Medical Devices" report has been added to ResearchAndMarkets.com's offering.
  • The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry.
  • The growth opportunities for all these advanced medical device technologies are also covered in this issue.
  • Innovations and Growth Opportunities in Novel Diagnostics, Monitoring Technologies and Advanced Medical Devices
    Wearable Patient Monitoring Help Improve Hospital Workflow Efficiency, Reduce Healthcare Costs, and Enhance Patient Outcomes

Virtual Store Platform Obsess Introduces First-of-Its-Kind Custom Avatar Technology

Retrieved on: 
Thursday, November 17, 2022

NEW YORK, Nov. 17, 2022 /PRNewswire-PRWeb/ -- Obsess, a leading experiential e-commerce platform enabling brands to create immersive virtual stores, today launched "Branded Avatars," a first-of-its-kind industry technology that enables brands to customize the look-and-feel and character style of shopper avatars to create branded metaverse experiences on their e-commerce sites. The new capability then lets shoppers personalize all aspects of their branded avatar, including skin tone, facial features, body shape, clothing and makeup.

Key Points: 
  • The new capability then lets shoppers personalize all aspects of their branded avatar, including skin tone, facial features, body shape, clothing and makeup.
  • "We're thrilled to launch this industry-first innovation and to push avatar technology forward for all consumers outside of gaming environments.
  • Our platform now enables brands to create their own custom metaverse on their sitewhere both the environment and avatar style match the brand's look-and-feelto give consumers an unforgettable shopping experience."
  • Obsess is a leading experiential e-commerce platform that enables retailers to create immersive, branded, discovery-driven virtual stores on their websites and on metaverse platforms.

Worldwide Optogenetics Industry to 2027 - Featuring Addgene, Coherent and Elliot Scientific Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, April 8, 2022

Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies.

Key Points: 
  • Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies.
  • It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors.
  • This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing.
  • What is the structure of the global optogenetics market and who are the key players?

Global Deep Brain Stimulation Devices Market (2021 to 2026) - Featuring Boston Scientific, Fisher Wallace and LivaNova Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 18, 2022

Global deep brain stimulation (DBS) devices market is expected to undergo substantial growth during the forecast period owing to increasing prevalence of neurological disorders around the world.

Key Points: 
  • Global deep brain stimulation (DBS) devices market is expected to undergo substantial growth during the forecast period owing to increasing prevalence of neurological disorders around the world.
  • With increasing investment on R&D activities in neurological sector, the global deep brain stimulation (DBS) devices market is anticipated to grow further in the coming years.
  • Deep brain stimulation devices are based on therapy which involves implantation of electrodes within certain areas of the brain.
  • Global deep brain stimulation (DBS) devices market can be segmented based on product type, type, application, end user and region.

Clinch Doubles Headcount to Support Exponential Business Growth Across a Number of Verticals, Including Connected TV (CTV), Over-the-top (OTT), Digital Out-of-Home (DOOH), and Audio

Retrieved on: 
Tuesday, November 30, 2021

We have retained an impressive client roster that has grown over 250% year-over-year, and we intend to keep that momentum going."

Key Points: 
  • We have retained an impressive client roster that has grown over 250% year-over-year, and we intend to keep that momentum going."
  • MacIntosh brings over two decades of sales and partnership-building experience to Clinch.
  • Additionally, Clinch has expanded its sales team to serve exponential account growth with leading agencies and Fortune 500 brands.
  • Having worked with companies such as Innovid, FlightAware, and RevJet, Malinoff brings a unique combination of expertise to Clinch.

MagVenture receives CE approvals for noninvasive brain treatment of addiction, OCD, and depression with anxiety symptoms

Retrieved on: 
Wednesday, April 28, 2021

b'COPENHAGEN, Denmark, April 28, 2021 /PRNewswire/ -- Global MedTech pioneer MagVenture has received CE approval for the treatment of addiction and Obsessive-Compulsive Disorder (OCD).

Key Points: 
  • b'COPENHAGEN, Denmark, April 28, 2021 /PRNewswire/ -- Global MedTech pioneer MagVenture has received CE approval for the treatment of addiction and Obsessive-Compulsive Disorder (OCD).
  • In addition, MagVenture TMS Therapy can reduce the symptoms of comorbid anxiety in patients suffering from depression.
  • "\nFor OCD, a 45% response rate was reported for the group receiving treatment, compared to 18% in the sham group.
  • "\nFor subjects responding to the treatment of MDD, who have symptoms of comorbid anxiety, the clinical benefit can additionally include an improvement of anxiety symptoms.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/magventure-receives-ce-approvals...\n'

MagVenture receives CE approvals for noninvasive brain treatment of addiction, OCD, and depression with anxiety symptoms

Retrieved on: 
Wednesday, April 28, 2021

b'COPENHAGEN, Denmark, April 28, 2021 /PRNewswire/ -- Global MedTech pioneer MagVenture has received CE approval for the treatment of addiction and Obsessive-Compulsive Disorder (OCD).

Key Points: 
  • b'COPENHAGEN, Denmark, April 28, 2021 /PRNewswire/ -- Global MedTech pioneer MagVenture has received CE approval for the treatment of addiction and Obsessive-Compulsive Disorder (OCD).
  • In addition, MagVenture TMS Therapy can reduce the symptoms of comorbid anxiety in patients suffering from depression.
  • "\nFor OCD, a 45% response rate was reported for the group receiving treatment, compared to 18% in the sham group.
  • "\nFor subjects responding to the treatment of MDD, who have symptoms of comorbid anxiety, the clinical benefit can additionally include an improvement of anxiety symptoms.\n'

nView Health Announces Expansion of Behavioral Health Solutions Portfolio to Include World's Leading Obsessive Compulsive Disorder Measurements

Retrieved on: 
Wednesday, April 14, 2021

b'ATLANTA, April 14, 2021 /PRNewswire-PRWeb/ --nView Health, the premier provider of evidence-based behavioral health solutions, is pleased to announce the addition of a series of new products to comprehensively address a series of mental health disorders specific to Obsessive Compulsive Disorder (OCD).

Key Points: 
  • b'ATLANTA, April 14, 2021 /PRNewswire-PRWeb/ --nView Health, the premier provider of evidence-based behavioral health solutions, is pleased to announce the addition of a series of new products to comprehensively address a series of mental health disorders specific to Obsessive Compulsive Disorder (OCD).
  • nView\'s OCD measurements include:\n"The addition of these world-renowned proprietary solutions is exciting and timely given the escalating global mental health crisis," said Dr. Thomas Young, Founder and Chief Medical Officer at nView Health.
  • "This is another large step forward for nView as we grow our digital platform of the world\'s leading behavioral health assessment technologies and make these solutions widely available to our research and healthcare provider customers around the world.
  • Anyone interested in using the OCD measurements or other exclusive nView assessment tools should reach out via our website, nview.com , to learn more about nView solutions and licensing.

An OCD survivor shares principles, tools and insight to help sufferers of OCD choose recovery over fear and get better

Retrieved on: 
Thursday, March 11, 2021

In Turning Points: Peer Support with a Strategy to Help Those Affected by Obsessive Compulsive Disorder (OCD) (published by Balboa Press), Shy shares a comprehensive guide that provides peer support and a proven strategy for recovering from OCD.

Key Points: 
  • In Turning Points: Peer Support with a Strategy to Help Those Affected by Obsessive Compulsive Disorder (OCD) (published by Balboa Press), Shy shares a comprehensive guide that provides peer support and a proven strategy for recovering from OCD.
  • He shares valuable information about the growing discipline of peer support, insight into how to build a recovery foundation, his strategy to overcome OCD, motivation, encouragement and tips for sufferers to self-motivate.
  • For those who have OCD, Shy wants them to know through this book that having OCD does not mean they are crazy.
  • I say without equivocation, you too can confront OCD and get to a place where OCD does not adversely affect your life.